This post was originally published on this site
“It has become even clearer to me that the best path forward for the (company) is for me to take the company private,” Wojcicki said.
Wojcicki had said earlier this month she would consider third-party takeover proposals while continuing to evaluate and negotiate a deal.
In July, the CEO and co-founder proposed to acquire all outstanding shares of the firm not already owned by her or her affiliates for $0.40 each.
The independent directors of the company resigned earlier this month saying they had not received a satisfactory take-private offer in the best interests of the non-affiliated shareholders.
23andMe, which provides DNA testing that helps users learn more about their ancestry, went public in 2021.
